Trial intelligence / Profile preview

Bryostatin-1 in Progressive Hypernephroma

NCT00005056Phase 2Completed

Sponsor
Cancer Research UK
Start
Mar 1999
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bryostatin-1 in renal cell carcinoma (RCC), sponsored by Cancer Research UK. Started Mar 1999; status: completed.

02

Drugs

bryostatin-1
03

Conditions

renal cell carcinoma (RCC)

Beyond the preview

Go deeper on NCT00005056.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00005056.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call